Greater change in bone turnover markers for efavirenz/emtricitabine/tenofovir disoproxil fumarate versus dolutegravir + abacavir/lamivudine in antiretroviral therapy-naive adults over 144 weeks

Antiretroviral therapy initiation has been linked to bone mineral density and bone biomarker changes. We assessed long-term bone turnover biomarker effects over 144 weeks in patients initiating dolutegravir (DTG) + abacavir/lamivudine (ABC/3TC) versus efavirenz/emtricitabine/tenofovir disoproxil fum...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:AIDS
Main Authors: Tebas, Pablo, Kumar, Princy, Hicks, Charles, Granier, Catherine, Wynne, Brian, Min, Sherene, Pappa, Keith
Format: Artigo
Jezik:Inglês
Izdano: Lippincott Williams & Wilkins 2015
Teme:
Clinical Science
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC4645955/
https://ncbi.nlm.nih.gov/pubmed/26355674
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/QAD.0000000000000863
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki